<SEC-DOCUMENT>0001193125-25-316569-index.html : 20251211 <SEC-HEADER>0001193125-25-316569.hdr.sgml : 20251211 <ACCEPTANCE-DATETIME>20251211205221 ACCESSION NUMBER: 0001193125-25-316569 CONFORMED SUBMISSION TYPE: SCHEDULE 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20251211 DATE AS OF CHANGE: 20251211 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Opus Genetics, Inc. CENTRAL INDEX KEY: 0001228627 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 113516358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79996 FILM NUMBER: 251566338 BUSINESS ADDRESS: STREET 1: 8 DAVIS DRIVE STREET 2: SUITE 220 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 248-681-9815 MAIL ADDRESS: STREET 1: 8 DAVIS DRIVE STREET 2: SUITE 220 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Ocuphire Pharma, Inc. DATE OF NAME CHANGE: 20201109 FORMER COMPANY: FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC DATE OF NAME CHANGE: 20030423 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Foundation Fighting Blindness Retinal Degeneration Fund CENTRAL INDEX KEY: 0002042266 ORGANIZATION NAME: EIN: 450524687 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A BUSINESS ADDRESS: STREET 1: 223 S. WEST STREET, SUITE 900 CITY: RALEIGH STATE: NC ZIP: 27603 BUSINESS PHONE: 800-683-5555 MAIL ADDRESS: STREET 1: 223 S. WEST STREET, SUITE 900 CITY: RALEIGH STATE: NC ZIP: 27603 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13D/A <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> </SEC-DOCUMENT>